Roivant Sciences Ltd. (87S)
FSX
Delayed Data
Oct 26, 2026, 07:00 AM
Day's Range
32.0052 wk Range
15.16Overview - 87S - Roivant Sciences Ltd.
Key Statistics
Valuation
Enterprise Value
18.33B
P/E (Trailing)
1.97
PEG Ratio
-0.09
Price / Sales (TTM)
3,103.34
Price / Book
6.20
EV / EBITDA
-15.26
Profitability
Gross Margin
80.30%
Profit Margin
84.44%
Operating Margin
-25,408.11%
Return on Assets
-16.27%
Return on Equity
-8.51%
Ownership
Shares Outstanding
722.66M
Float
582.19M
Held by Insiders
21.38%
Held by Institutions
78.44%
Price stats
Beta
1.10
50-Day Avg
31.43
200-Day Avg
26.79
Dividends
Payout Ratio
0.00%
Market Cap - 87S - Roivant Sciences Ltd.
Peers - 87S - Roivant Sciences Ltd.
Peer Comparison
Compared with companies in Biotechnology listed on FSX.
- 87SFSXRoivant Sciences Ltd.23.37BMarket Cap+49.35%52-week change1.97P/E (Trailing)84.44%Profit Margin
- ANLFSXAnalog Devices, Inc.166.10BMarket Cap+40.40%52-week change47.41P/E (Trailing)29.78%Profit Margin
- 0QFFSXModerna Inc.74.60BMarket Cap+88.69%52-week change25.27P/E (Trailing)-141.42%Profit Margin
- 1AEFSXargenx SE48.77BMarket Cap+8.36%52-week change31.83P/E (Trailing)31.73%Profit Margin
- 1AEAFSXargenx SE American Depositary Receipt45.90BMarket Cap-5.00%52-week change32.46P/E (Trailing)32.26%Profit Margin
- 64BFSXAstera Labs, Inc.40.42BMarket Cap+41.34%52-week change133.91P/E (Trailing)30.74%Profit Margin
- 49BAFSXBeOne Medicines Ltd. American Depositary Shares37.54BMarket Cap+19.39%52-week change69.73P/E (Trailing)10.69%Profit Margin
Profile Summary - 87S - Roivant Sciences Ltd.
About
Roivant Sciences Ltd. is a biopharmaceutical company focused on discovering, developing, and commercializing medicines and technologies through a portfolio of specialized subsidiary companies. Roivant Sciences Ltd. operates across immunology, dermatology, and other high-unmet-need therapeutic areas, with current work…
The information on this page is provided for general informational purposes only and is not investment advice.
Market data provided by Twelve Data. Charting by TradingView.
Last updated:
